Beraprost Sodium Modified Release

( DrugBank: Beraprost / KEGG DRUG: Beraprost )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	19

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 10 of 19 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01966302 (ClinicalTrials.gov)	November 2013	15/10/2013	Compassionate Use of Beraprost Sodium314d Modified Releasefor Patients With Pulmonary Arterial Hyper ...	Compassionate Use of Beraprost Sodium314d Modified Release(BPS-314d-MR) for Three Patients With Pulm ...	Pulmonary Arterial Hypertension	Drug: BPS-314d-MR	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Lung Biotechnology PBC	Completed	18 Years	75 Years	All	1	Phase 2	United States
2	NCT01908699 (ClinicalTrials.gov)	May 31, 2013	16/7/2013	Beraprost-314d Added-on to Tyvaso® (BEAT)	A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy an ...	Pulmonary Arterial Hypertension	Drug: Beraprost Sodium 314d Modified Release Tablets;Drug: Placebo	Lung Biotechnology PBC	NULL	Completed	18 Years	80 Years	All	273	Phase 3	United States;Israel
3	NCT01458236 (ClinicalTrials.gov)	November 2011	29/9/2011	A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects Wit ...	A Multinational, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase III Study to Asses ...	Pulmonary Arterial Hypertension	Drug: Beraprost Sodium 314d Modified Release Tablets;Drug: Placebo	Lung Biotechnology Inc.	NULL	Withdrawn	18 Years	80 Years	Both	0	Phase 3	NULL
4	EUCTR2009-014453-32-CZ (EUCTR)	15/07/2010	11/02/2010	NA	An open-label extension of BPS-MR-PAH-203 in pulmonary arterial hypertension (PAH) patients	Pulmonary Arterial Hypertension MedDRA version: 14.1;Level: PT;Classification code 10064911;Term: Pu ...	Product Name: Beraprost Sodium Modified Release Product Code: BPS-MR INN or Proposed INN: Beraprost So ...	Lung LLC	NULL	Not Recruiting			Female: yes Male: yes	36		Czech Republic;Belgium;Ireland;Germany
5	EUCTR2009-014246-29-DE (EUCTR)	08/04/2010	16/11/2009	A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy ...	A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy ...	Pulmonary Arterial Hypertension MedDRA version: 12.0;Level: LLT;Classification code 10064911;Term: P ...	Product Name: Beraprost Sodium Modified Release Product Code: BPS-MR INN or Proposed INN: Beraprost So ...	Lung Rx	NULL	Not Recruiting			Female: yes Male: yes	36	Phase 2	Czech Republic;Belgium;Ireland;Germany
6	EUCTR2009-014246-29-CZ (EUCTR)	18/02/2010	07/12/2009	A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy ...	A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy ...	Pulmonary Arterial Hypertension MedDRA version: 13.1;Level: PT;Classification code 10064911;Term: Pu ...	Product Name: Beraprost Sodium Modified Release Product Code: BPS-MR INN or Proposed INN: Beraprost So ...	Lung Rx Inc	NULL	Not Recruiting			Female: yes Male: yes	36		Germany;Czech Republic;Belgium;Ireland
7	EUCTR2009-014246-29-IE (EUCTR)	01/02/2010	06/11/2009	A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy ...	A 12-week, double-blind, international, multicenter, dose-response study of the safety and efficacy ...	Pulmonary Arterial Hypertension MedDRA version: 12.0;Level: LLT;Classification code 10064911;Term: P ...	Product Name: Beraprost Sodium Modified Release Product Code: BPS-MR INN or Proposed INN: Beraprost So ...	Lung Rx	NULL	Not Recruiting			Female: yes Male: yes	36		Czech Republic;Germany;Belgium;Ireland
8	EUCTR2009-014453-32-IE (EUCTR)	01/02/2010	09/11/2009	An open-label extension of BPS-MR-PAH-203 in pulmonary arterial hypertension (PAH) patients	An open-label extension of BPS-MR-PAH-203 in pulmonary arterial hypertension (PAH) patients	Pulmonary Arterial Hypertension MedDRA version: 14.1;Level: PT;Classification code 10064911;Term: Pu ...	Product Name: Beraprost Sodium Modified Release Product Code: BPS-MR INN or Proposed INN: Beraprost So ...	Lung LLC Inc	NULL	Not Recruiting			Female: yes Male: yes	36		Czech Republic;Belgium;Ireland;Germany
9	NCT00989963 (ClinicalTrials.gov)	February 1, 2010	5/10/2009	Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release(BPS-MR) in Patie ...	A 12-week, Double-blind, International, Multicenter, Dose-response Study of the Safety and Efficacy ...	Pulmonary Arterial Hypertension	Drug: Beraprost Sodium Modified Release	Lung Biotechnology PBC	NULL	Completed	18 Years	75 Years	All	36	Phase 2	United States;Belgium;Czechia;Germany;Ireland;Romania;Czech Republic
10	EUCTR2009-014453-32-BE (EUCTR)	11/01/2010	09/11/2009	An open-label extension of BPS-MR-PAH-203 in pulmonary arterial hypertension (PAH) patients	An open-label extension of BPS-MR-PAH-203 in pulmonary arterial hypertension (PAH) patients	Pulmonary Arterial Hypertension MedDRA version: 14.1;Level: PT;Classification code 10064911;Term: Pu ...	Product Name: Beraprost Sodium Modified Release Product Code: BPS-MR INN or Proposed INN: Beraprost So ...	Lung LLC	NULL	Not Recruiting			Female: yes Male: yes	36	Phase 2	United States;Czech Republic;Belgium;Ireland;Romania;Germany

First Previous1 2Next Last